Skip to content
10-Q

Quarterly Report

Design Therapeutics, Inc. DSGN

0000950170-25-105062

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 56.95M sh
Shares Diluted Q2 2025 · Jun 30, 2025 56.86M sh
Shares Diluted Q2 2025 · Jun 30, 2025 56.81M sh
Shares Diluted Q2 2025 · Jun 30, 2024 56.56M sh
Shares Diluted Q2 2025 · Jun 30, 2024 56.52M sh
Capex Q2 2025 · Jun 30, 2025 $159K
Capex Q2 2025 · Jun 30, 2024 $356K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$31.23M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$23.7M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $19.7M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $22.56M
Stockholders Equity Q2 2025 · Jun 30, 2025 $213.04M
Stockholders Equity Q2 2025 · Mar 31, 2025 $227.92M
Stockholders Equity Q2 2025 · Dec 31, 2024 $242.1M
Stockholders Equity Q2 2025 · Jun 30, 2024 $261.24M
Stockholders Equity Q2 2025 · Mar 31, 2024 $269.56M
Stockholders Equity Q2 2025 · Dec 31, 2023 $277.69M
Current Liabilities Q2 2025 · Jun 30, 2025 $8.75M
Current Liabilities Q2 2025 · Dec 31, 2024 $8.46M
Total Liabilities Q2 2025 · Jun 30, 2025 $9.85M
Total Liabilities Q2 2025 · Dec 31, 2024 $10M
Current Assets Q2 2025 · Jun 30, 2025 $219.79M
Current Assets Q2 2025 · Dec 31, 2024 $248.04M
Total Assets Q2 2025 · Jun 30, 2025 $222.89M
Total Assets Q2 2025 · Dec 31, 2024 $252.09M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.34
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.65
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.21
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.41
Eps Basic Q2 2025 · Jun 30, 2025 −$0.34
Eps Basic Q2 2025 · Jun 30, 2025 −$0.65
Eps Basic Q2 2025 · Jun 30, 2024 −$0.21
Eps Basic Q2 2025 · Jun 30, 2024 −$0.41
Sga Expense Q2 2025 · Jun 30, 2025 $5.83M
Sga Expense Q2 2025 · Jun 30, 2025 $10.87M
Sga Expense Q2 2025 · Jun 30, 2024 $4.53M
Sga Expense Q2 2025 · Jun 30, 2024 $9.13M
Rd Expense Q2 2025 · Jun 30, 2025 $15.74M
Rd Expense Q2 2025 · Jun 30, 2025 $31.12M
Rd Expense Q2 2025 · Jun 30, 2024 $10.52M
Rd Expense Q2 2025 · Jun 30, 2024 $20.32M
Net Income Q2 2025 · Jun 30, 2025 −$19.08M
Net Income Q2 2025 · Jun 30, 2025 −$36.8M
Net Income Q2 2025 · Jun 30, 2024 −$11.79M
Net Income Q2 2025 · Jun 30, 2024 −$22.9M
Operating Income Q2 2025 · Jun 30, 2025 −$21.57M
Operating Income Q2 2025 · Jun 30, 2025 −$41.99M
Operating Income Q2 2025 · Jun 30, 2024 −$15.04M
Operating Income Q2 2025 · Jun 30, 2024 −$29.44M